ProThera Biologics Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
6
- Latest Deal Type
-
2ndary - Private
- Investors
-
2
ProThera Biologics General Information
Description
Developer of integrated theranostic and therapeutic biomolecules designed to treat life-threatening inflammatory diseases. The company's biomolecules help control inflammation by modulating multiple pathways and play a role in tissue repair, enabling doctors to effectively treat diseases such as sepsis and cancer.
Contact Information
Website
www.protherabiologics.comCorporate Office
- 349 Eddy Street
- Providence, RI 02903
- United States
Corporate Office
- 349 Eddy Street
- Providence, RI 02903
- United States
ProThera Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 19. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 18. Grant | 19-Jun-2019 | Completed | Generating Revenue | |||
| 17. Later Stage VC | 04-Jan-2019 | Completed | Generating Revenue | |||
| 16. Grant | 15-Aug-2018 | Completed | Generating Revenue | |||
| 15. Grant | 15-Jun-2017 | Completed | Generating Revenue | |||
| 14. Later Stage VC | 26-Sep-2016 | Completed | Generating Revenue | |||
| 13. Grant | 17-Sep-2015 | Completed | Generating Revenue | |||
| 12. Grant | 01-Jan-2014 | Completed | Generating Revenue | |||
| 11. Later Stage VC | 05-Sep-2012 | $250K | $750K | Completed | Generating Revenue | |
| 10. Grant | 01-Jan-2012 | $498K | $500K | Completed | Generating Revenue |
ProThera Biologics Patents
ProThera Biologics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230055086-A1 | Inter-alpha inhibitor proteins | Inactive | 19-Aug-2021 | ||
| AU-2021377336-A1 | Methods for purifying inter-alpha inhibitor proteins | Pending | 16-Nov-2020 | ||
| AU-2021377336-A9 | Methods for purifying inter-alpha inhibitor proteins | Pending | 16-Nov-2020 | ||
| CA-3198925-A1 | Methods for purifying inter-alpha inhibitor proteins | Pending | 16-Nov-2020 | ||
| EP-4244629-A1 | Methods for purifying inter-alpha inhibitor proteins | Pending | 16-Nov-2020 | G01N33/6893 |
ProThera Biologics Signals
ProThera Biologics Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Liminal R and D BioSciences | Corporation | |||
| National Institute for Allergy and Infectious Disease | Government |
ProThera Biologics FAQs
-
When was ProThera Biologics founded?
ProThera Biologics was founded in 2001.
-
Where is ProThera Biologics headquartered?
ProThera Biologics is headquartered in Providence, RI.
-
What is the size of ProThera Biologics?
ProThera Biologics has 6 total employees.
-
What industry is ProThera Biologics in?
ProThera Biologics’s primary industry is Drug Discovery.
-
Is ProThera Biologics a private or public company?
ProThera Biologics is a Private company.
-
What is ProThera Biologics’s current revenue?
The current revenue for ProThera Biologics is .
-
How much funding has ProThera Biologics raised over time?
ProThera Biologics has raised $2.75M.
-
Who are ProThera Biologics’s investors?
Liminal R and D BioSciences and National Institute for Allergy and Infectious Disease have invested in ProThera Biologics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process